GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Net Issuance of Preferred Stock

Q2M Biotech AG (HAM:QBI) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Q2M Biotech AG's net issuance of preferred for the three months ended in . 20 was €0.00 Mil. The number is 0, which means that Q2M Biotech AG has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Q2M Biotech AG's net issuance of preferred for the trailing twelve months (TTM) ended in . 20 was €0.00 Mil.


Q2M Biotech AG Net Issuance of Preferred Stock Historical Data

The historical data trend for Q2M Biotech AG's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Net Issuance of Preferred Stock Chart

Q2M Biotech AG Annual Data
Trend
Net Issuance of Preferred Stock

Q2M Biotech AG Quarterly Data
Net Issuance of Preferred Stock

Q2M Biotech AG Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q2M Biotech AG Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines